Brief: Alebund Pharmaceuticals (Jiangsu) Board Resolves To Repurchase H Shares Up To Hk$100 MillionTue 18:43
Brief: Alebund Pharmaceuticals (Jiangsu) Says IND Application For AP308 Cleared By U.S. FDA08/09/2026 16:21
Brief: Alebund Pharmaceuticals (Jiangsu) Sets Final Offer Price At HK$22.6 Per Offer Share26/06/2026 16:37